Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adynovate perioperative special drug use survey in hemophilia A
jRCT2031210173Completed
- Sponsor
- Takeda
- Start
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of recombinant coagulation factor viii in hemophilia A, sponsored by Takeda. Primary endpoints: Number of participants with adverse events, Number of participants with serious adverse events and 3 more. Started Jun 2021; status: completed.
02
Drugs
recombinant coagulation factor viii
03
Conditions
hemophilia A
Beyond the preview
Go deeper on jRCT2031210173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210173.